0,721  0,003  GABA C receptor rho-3 antagonist
0,634  0,004  Antineoplastic (bladder cancer)
0,637  0,012  CYP1A2 substrate
0,572  0,026  Antineoplastic (colorectal cancer)
0,563  0,026  Antineoplastic (colon cancer)
0,555  0,019  Aryl hydrocarbon receptor agonist
0,549  0,017  Immunomodulator
0,526  0,005  DNA intercalator
0,523  0,005  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,530  0,017  Ulceration
0,491  0,009  Antineoplastic (small cell lung cancer)
0,478  0,004  Telomerase inhibitor
0,479  0,024  MAP kinase kinase 6 inhibitor
0,489  0,038  CYP2C9 substrate
0,475  0,027  Antineoplastic (melanoma)
0,499  0,060  Caspase 9 stimulant
0,451  0,019  DNA damaging
0,464  0,032  Antiprotozoal (Plasmodium)
0,439  0,012  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,464  0,038  Aldehyde oxidase inhibitor
0,445  0,025  Antineoplastic (non-small cell lung cancer)
0,410  0,003  GABA C receptor rho-2 antagonist
0,416  0,016  Antineoplastic (lymphocytic leukemia)
0,402  0,005  Toll-Like receptor 9 antagonist
0,395  0,005  Topoisomerase I inhibitor
0,404  0,017  FMO3 substrate
0,425  0,038  FMO1 substrate
0,441  0,056  Antineoplastic (lung cancer)
0,386  0,006  MAP-kinase-activated kinase 5 inhibitor
0,441  0,068  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,396  0,025  Antineoplastic (renal cancer)
0,373  0,005  GABA receptor agonist
0,426  0,059  Antiprotozoal
0,385  0,020  Ca2+/calmodulin-dependent protein kinase inhibitor
0,446  0,082  Antineoplastic (solid tumors)
0,358  0,009  Cytokine production inhibitor
0,347  0,005  MAP kinase 12 inhibitor
0,367  0,025  Flavin-containing monooxygenase substrate
0,346  0,005  Ferrochelatase inhibitor
0,368  0,028  Pyruvate kinase inhibitor
0,387  0,048  5 Hydroxytryptamine release stimulant
0,362  0,024  Ca2+/calmodulin-dependent kinase II gamma inhibitor
0,394  0,066  CYP2C19 inhibitor
0,338  0,013  Ca2+/calmodulin-dependent kinase IV inhibitor
0,358  0,035  Antineoplastic (glioblastoma multiforme)
0,326  0,005  Protein kinase C zeta inhibitor
0,315  0,005  MAP kinase 13 inhibitor
0,354  0,045  Antineoplastic (glioma)
0,311  0,004  Antiprotozoal (Babesia)
0,322  0,016  Topoisomerase II inhibitor
0,359  0,055  Anxiolytic
0,329  0,029  Antiparkinsonian, rigidity relieving
0,304  0,004  Protein kinase C gamma inhibitor
0,301  0,005  GABA A receptor agonist
0,305  0,011  Ribosomal protein S6 kinase inhibitor
0,341  0,048  Hypoxia-inducible factor 1 alpha inhibitor
0,296  0,005  Protein kinase C mu inhibitor
0,299  0,010  Aldehyde oxidase substrate
0,345  0,059  Antineoplastic (ovarian cancer)
0,333  0,049  Antineoplastic (cervical cancer)
0,362  0,079  Antineoplastic (myeloid leukemia)
0,310  0,031  Sedative
0,302  0,023  Pneumotoxic
0,287  0,008  Toll-Like receptor antagonist
0,301  0,024  Protein kinase C nu inhibitor
0,304  0,030  Gastrin inhibitor
0,350  0,081  Antileukemic
0,300  0,035  MAP kinase kinase 2 inhibitor
0,317  0,053  CYP1A2 inhibitor
0,343  0,081  CYP3A4 substrate
0,380  0,118  MAP kinase 1 inhibitor
0,317  0,058  Antineoplastic (osteosarcoma)
0,262  0,007  Polo-like kinase-4 inhibitor
0,293  0,038  EphB2 antagonist
0,274  0,020  CNS active muscle relaxant
0,351  0,099  Histamine release inhibitor
0,265  0,013  Butyrylcholinesterase inhibitor
0,367  0,115  Alzheimer's disease treatment
0,256  0,005  Photosensitizer
0,251  0,004  GABA C receptor rho-1 antagonist
0,253  0,010  Antiprotozoal (Amoeba)
0,289  0,046  Cyclic AMP phosphodiesterase inhibitor
0,334  0,091  CYP2C9 inhibitor
0,290  0,055  GST M1-1 substrate
0,313  0,080  Prostate cancer treatment
0,265  0,031  LIM domain kinase 1 inhibitor
0,286  0,057  Antineoplastic (liver cancer)
0,305  0,077  Antineoplastic (brain cancer)
0,234  0,006  Antineoplastic alkaloid
0,280  0,056  Antineoplastic (lymphoma)
0,280  0,059  Interleukin agonist
0,286  0,066  Huntington's disease treatment
0,226  0,008  Hematopoietic
0,278  0,060  Dyrk kinase inhibitor
0,253  0,037  Neurotrophic factor enhancer
0,223  0,007  MAP kinase 11 inhibitor
0,219  0,004  Protein kinase C eta inhibitor
0,250  0,035  Antiviral (West Nile virus)
0,250  0,037  I kappa B kinase epsilon inhibitor
0,221  0,009  GABA C receptor antagonist
0,271  0,062  Superoxide dismutase inhibitor
0,276  0,068  Antiprotozoal (Trypanosoma)
0,268  0,060  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,231  0,024  MAO A inhibitor
0,216  0,009  Interleukin 8 antagonist
0,267  0,066  5 Hydroxytryptamine uptake stimulant
0,259  0,060  Tyrosine 3 hydroxylase inhibitor
0,343  0,143  Apoptosis agonist
0,202  0,004  Bromodomain-containing protein 2 inhibitor
0,270  0,073  UGT1A9 substrate
0,268  0,073  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,205  0,012  NAT2 substrate
0,195  0,005  Benzodiazepine agonist
0,235  0,045  UGT1A4 substrate
0,192  0,006  MAP-kinase-activated kinase inhibitor
0,218  0,033  Antiviral (Hepatitis C)
0,190  0,006  GABA A receptor antagonist
0,190  0,006  GABA receptor antagonist
0,198  0,014  Activin receptor-like kinase 4 inhibitor
0,211  0,030  Acetylcholinesterase inhibitor
0,259  0,078  Radiosensitizer
0,216  0,036  Skeletal muscle relaxant
0,262  0,084  Antituberculosic
0,296  0,121  Antineoplastic (breast cancer)
0,191  0,016  Topoisomerase II alpha inhibitor
0,220  0,046  Antiviral (Hepatitis)
0,178  0,005  MAP-kinase-activated kinase 2 inhibitor
0,203  0,031  Interleukin 1 antagonist
0,212  0,042  Antiviral (Ebola)
0,213  0,044  5 Hydroxytryptamine 3E antagonist
0,220  0,055  Focal adhesion kinase 2 inhibitor
0,172  0,008  Protein kinase C alpha inhibitor
0,253  0,090  CYP2C19 substrate
0,205  0,044  Cholinergic
0,243  0,082  5 Hydroxytryptamine 1E antagonist
0,214  0,055  Peroxidase inhibitor
0,173  0,015  MAP kinase 14 inhibitor
0,198  0,040  Protein kinase (CK1) inhibitor
0,196  0,040  ATPase inhibitor
0,194  0,038  Carcinogenic, group 1
0,258  0,103  Antimycobacterial
0,194  0,040  Activin receptor-like kinase 2 inhibitor
0,177  0,023  Fibroblast growth factor 1 antagonist
0,179  0,026  Excitatory amino acid transporter EAAC1 inhibitor
0,181  0,029  Antiprotozoal (Trichomonas)
0,167  0,015  Platelet growth factor antagonist
0,156  0,004  Protein kinase C beta inhibitor
0,170  0,018  DNA repair enzyme inhibitor
0,196  0,044  Neuropathy treatment
0,225  0,075  UGT1A6 substrate
0,185  0,034  Protein kinase (CK1) delta inhibitor
0,151  0,006  Protein kinase C epsilon inhibitor
0,200  0,056  VEGF expression inhibitor
0,164  0,021  Protein kinase A inhibitor
0,162  0,022  Obsessive-compulsive disorder treatment
0,252  0,114  CYP3A4 inhibitor
0,186  0,048  Antiparkinsonian, tremor relieving
0,178  0,041  NADPH oxidase inhibitor
0,177  0,043  Tyrosine-protein kinase receptor FLT3 inhibitor
0,201  0,068  Mutagenic
0,155  0,022  Creatine kinase inhibitor
0,211  0,078  ErbB-1 antagonist
0,150  0,018  Interleukin 2 antagonist
0,180  0,048  Glycogen synthase kinase-3 alpha inhibitor
0,159  0,029  Heat shock protein 70 antagonist
0,148  0,019  Pim-3 kinase inhibitor
0,206  0,078  Anticonvulsant
0,198  0,069  CYP2B6 inhibitor
0,260  0,134  GST A substrate
0,151  0,025  Sphingosine 1-phosphate receptor 2 agonist
0,161  0,036  Pregnane X receptor agonist
0,259  0,136  Calcium channel activator
0,168  0,045  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,181  0,057  Restenosis treatment
0,130  0,008  Transforming growth factor beta 3 antagonist
0,164  0,042  MAP3K9 inhibitor
0,145  0,023  Carcinogenic, group 2A
0,125  0,004  Antidote, organophosphates
0,124  0,004  Glutamate (mGluR7) antagonist
0,175  0,056  Cyclin-dependent kinase 8 inhibitor
0,148  0,028  Pim-1 kinase inhibitor
0,228  0,108  UGT2B4 substrate
0,124  0,005  Cyclin D1 inhibitor
0,226  0,107  Radioprotector
0,203  0,084  VCAM1 expression inhibitor
0,129  0,012  Caspase 7 inhibitor
0,171  0,054  CDC-like kinase 1 inhibitor
0,195  0,078  Osteoarthritis treatment
0,183  0,066  Muscle relaxant
0,233  0,116  CYP2D6 substrate
0,168  0,052  MAO inhibitor
0,136  0,020  Histamine N-methyltransferase inhibitor
0,194  0,081  Amyloid beta aggregation inhibitor
0,124  0,011  5 Hydroxytryptamine 5A antagonist
0,222  0,109  Chemoprotective
0,127  0,015  Interferon agonist
0,148  0,036  5 Hydroxytryptamine 3A agonist
0,229  0,118  Insulysin inhibitor
0,151  0,040  Cystathionine beta-synthase inhibitor
0,134  0,024  NAD(P)H dehydrogenase (quinone) inhibitor
0,130  0,021  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,198  0,088  Antiparasitic
0,204  0,097  Antiamyloidogenic
0,120  0,013  Transforming growth factor antagonist
0,117  0,010  Bromodomain-containing protein 4 inhibitor
0,172  0,065  UGT2B10 substrate
0,157  0,050  Antiseptic
0,118  0,012  5 Hydroxytryptamine 5 antagonist
0,159  0,054  Hearing loss treatment
0,140  0,035  Check point kinase 2 inhibitor
0,120  0,015  I kappa B kinase 1 inhibitor
0,130  0,025  Porphobilinogen synthase inhibitor
0,118  0,014  5 Hydroxytryptamine 3 antagonist
0,250  0,146  Cognition disorders treatment
0,129  0,025  Thioredoxin inhibitor
0,212  0,109  Antineoplastic (sarcoma)
0,192  0,089  Antimitotic
0,158  0,056  MAP kinase 3 inhibitor
0,107  0,005  MAP kinase 7 inhibitor
0,115  0,013  Toll-Like receptor 7 antagonist
0,171  0,070  Src kinase inhibitor
0,200  0,100  Antiprotozoal (Leishmania)
0,150  0,051  MAP kinase kinase inhibitor
0,209  0,110  DNA synthesis inhibitor
0,134  0,035  Multidrug resistance-associated protein 1 inhibitor
0,205  0,108  MAP kinase kinase 3 inhibitor
0,168  0,071  Death-associated protein kinase 2 inhibitor
0,147  0,050  Ca2+-transporting ATPase inhibitor
0,116  0,019  Granulocyte macrophage colony stimulating factor agonist
0,128  0,032  Protein kinase C delta inhibitor
0,116  0,021  Glycine receptor antagonist
0,103  0,009  Potassium channel (Ca-activated) blocker
0,098  0,005  GABA B receptor antagonist
0,138  0,046  5 Hydroxytryptamine 2B antagonist
0,116  0,025  Glutamate release inhibitor
0,148  0,057  Nav1.6 sodium channel blocker
0,104  0,014  5 Hydroxytryptamine 6 antagonist
0,105  0,014  5 Hydroxytryptamine 3A antagonist
0,162  0,072  Polo-like kinase-3 inhibitor
0,155  0,065  Thiol protease inhibitor
0,165  0,075  Catenin beta inhibitor
0,118  0,029  Antidote, mercury
0,133  0,044  MAP kinase 9 inhibitor
0,169  0,080  Antineoplastic (bone cancer)
0,117  0,028  I kappa B kinase inhibitor
0,101  0,012  Interferon inducer
0,113  0,027  Antileprosy
0,129  0,045  Antiviral (Poxvirus)
0,135  0,051  Glycogen synthase kinase-3 beta inhibitor
0,139  0,056  Antismoking
0,114  0,032  NADH dehydrogenase inhibitor
0,155  0,073  Urolithiasis treatment
0,169  0,087  DNA methyltransferase I inhibitor
0,115  0,033  Polo-like kinase-1 inhibitor
0,150  0,069  Genotoxic
0,089  0,009  Lysine-specific demethylase 1A inhibitor
0,086  0,006  5 Hydroxytryptamine 3B antagonist
0,160  0,080  Neurotensin receptor agonist
0,213  0,133  Antihypoxic
0,190  0,111  Cytostatic
0,087  0,008  Potassium channel small-conductance Ca-activated blocker
0,091  0,012  Toll-Like receptor 8 antagonist
0,175  0,097  DNA methylase inhibitor
0,202  0,126  Antineoplastic (pancreatic cancer)
0,149  0,073  Movement disorders treatment
0,084  0,008  Bromodomain-containing protein 3 inhibitor
0,126  0,050  Transcription factor STAT6 inhibitor
0,093  0,020  MAP kinase kinase 7 inhibitor
0,107  0,033  CYP2A6 inhibitor
0,145  0,072  Antineoplastic (carcinoma)
0,078  0,005  Cytokine production stimulant
0,149  0,077  Antinephritic
0,077  0,005  Benzodiazepine antagonist
0,087  0,015  AMPA receptor antagonist
0,113  0,042  MAP kinase kinase 1 inhibitor
0,088  0,018  Pim-2 kinase inhibitor
0,128  0,059  Beta amyloid protein antagonist
0,092  0,022  Narcolepsy treatment
0,090  0,020  5 Hydroxytryptamine 3 agonist
0,087  0,018  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,127  0,059  Contraceptive female
0,112  0,044  Prolactin inhibitor
0,108  0,041  5 Hydroxytryptamine 2C antagonist
0,121  0,055  SULT1A1 substrate
0,107  0,041  Arylamine N-Acetyltransferase substrate
0,069  0,004  Retinoid X receptor antagonist
0,171  0,106  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,126  0,061  5 Hydroxytryptamine antagonist
0,116  0,052  Alpha 2c adrenoreceptor antagonist
0,133  0,069  Tubulin antagonist
0,159  0,095  Phobic disorders treatment
0,164  0,100  Anesthetic general
0,113  0,050  GST T1-1 substrate
0,126  0,063  Alkylator
0,088  0,025  S-adenosyl-L-methionine decarboxylase inhibitor
0,095  0,032  Antiviral (RSV)
0,168  0,105  Interleukin antagonist
0,068  0,006  Antiviral (Bovine viral diarrhea virus)
0,098  0,036  Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor
0,114  0,052  CDC-like kinase 3 inhibitor
0,093  0,031  Cyclin B3 inhibitor
0,076  0,014  Topoisomerase II beta inhibitor
0,078  0,018  Phosphodiesterase 1A inhibitor
0,101  0,042  Leucine-rich repeat kinase 2 inhibitor
0,104  0,044  Antifungal (Candida)
0,116  0,056  Carcinogenic, group 2B
0,116  0,057  Myasthenia Gravis treatment
0,074  0,015  5 Hydroxytryptamine 1B agonist
0,120  0,061  Glycogen synthase kinase-3 inhibitor
0,096  0,037  MAP kinase 10 inhibitor
0,095  0,036  Fibroblast growth factor 3 antagonist
0,061  0,004  Retinoid X alpha receptor antagonist
0,160  0,104  Antirickettsial
0,091  0,036  5 Hydroxytryptamine 1F antagonist
0,100  0,045  Phosphodiesterase I inhibitor
0,092  0,038  Nicotinic alpha4beta2 receptor antagonist
0,137  0,082  Antimutagenic
0,114  0,059  Acetylcholine release stimulant
0,165  0,111  Growth factor agonist
0,074  0,020  mTOR inhibitor
0,159  0,106  Clk dual-specificity kinase inhibitor
0,085  0,032  CDC7 inhibitor
0,071  0,018  Myc inhibitor
0,104  0,052  Interleukin 1 beta converting enzyme inhibitor
0,093  0,042  mTOR complex 2 inhibitor
0,199  0,148  CYP2D6 inhibitor
0,105  0,055  Insulin receptor antagonist
0,117  0,067  Aurora-B kinase inhibitor
0,132  0,083  Mannose-6-phosphate isomerase inhibitor
0,127  0,078  Cyclin-dependent kinase 7 inhibitor
0,209  0,160  CTGF expression inhibitor
0,091  0,043  D-Ala-D-Ala ligase inhibitor
0,072  0,025  Corticotropin releasing factor 2 receptor antagonist
0,228  0,181  Antineoplastic (non-Hodgkin's lymphoma)
0,054  0,007  ATM kinase inhibitor
0,150  0,104  Antineoplastic (gastric cancer)
0,072  0,025  Fibroblast growth factor 4 antagonist
0,137  0,092  MAP kinase kinase 4 inhibitor
0,128  0,082  Antineoplastic (squamous cell carcinoma)
0,106  0,060  Antifungal (Aspergillus)
0,053  0,008  Cyclin E2 inhibitor
0,110  0,066  Alpha 2b adrenoreceptor antagonist
0,079  0,035  5 Hydroxytryptamine 1B antagonist
0,128  0,085  Growth factor antagonist
0,103  0,060  Platelet activating factor beta antagonist
0,137  0,094  UGT1A3 substrate
0,072  0,029  Cyclin-dependent kinase 6 inhibitor
0,075  0,032  Aryl hydrocarbon receptor antagonist
0,122  0,080  Antihelmintic (Trematoda)
0,205  0,164  Angiogenesis inhibitor
0,124  0,083  Lck kinase inhibitor
0,155  0,114  Death-associated protein kinase 3 inhibitor
0,132  0,092  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,085  0,046  Macrophage migration inhibitory factor inhibitor
0,079  0,040  Prostaglandin-E synthase inhibitor
0,074  0,035  5 Hydroxytryptamine 1D antagonist
0,076  0,037  Acetylcholine M5 receptor agonist
0,121  0,083  Ca2+/calmodulin-dependent kinase II delta inhibitor
0,072  0,034  Antihemophilic
0,058  0,020  Phosphodiesterase 3B inhibitor
0,120  0,082  Proto-oncogene tyrosine-protein kinase Yes inhibitor
0,045  0,007  Adenosine uptake inhibitor
0,076  0,038  Phosphodiesterase III inhibitor
0,166  0,128  Fibrosis treatment
0,062  0,024  Transforming growth factor beta 1 antagonist
0,134  0,097  UGT2B9 substrate
0,055  0,019  Benzodiazepine inverse agonist
0,130  0,094  Antianemic
0,068  0,032  Phosphodiesterase 1B inhibitor
0,069  0,033  I kappa B kinase 2 inhibitor
0,068  0,032  Phosphodiesterase 1C inhibitor
0,065  0,030  Fatty acid synthase inhibitor
0,099  0,064  Cyclin-dependent kinase 9 inhibitor
0,085  0,050  Thioredoxin reductase inhibitor
0,097  0,063  Electrolyte absorption antagonist
0,043  0,009  Estrogen-related receptor beta antagonist
0,102  0,069  Antiprotozoal (Toxoplasma)
0,086  0,053  Histamine H2 receptor antagonist
0,056  0,023  Histamine H4 receptor antagonist
0,201  0,168  Transcription factor NF kappa B inhibitor
0,041  0,008  Protein kinase C beta I inhibitor
0,102  0,070  5 Hydroxytryptamine 2 antagonist
0,061  0,030  5 Hydroxytryptamine 7 agonist
0,150  0,119  UGT1A1 substrate
0,123  0,093  UGT2B15 substrate
0,063  0,033  Protein kinase C theta inhibitor
0,089  0,060  Actinic keratosis treatment
0,070  0,040  MAP kinase kinase 10 inhibitor
0,116  0,087  Antiviral (Papilloma)
0,158  0,129  Histone acetyltransferase inhibitor
0,194  0,166  Nootropic
0,076  0,047  Ankylosing spondylitis treatment
0,078  0,050  Alpha 2a adrenoreceptor antagonist
0,136  0,108  Interleukin-1 receptor-associated protein kinase 1 inhibitor
0,101  0,073  Antihelmintic (Fasciola)
0,056  0,030  Aconitate hydratase inhibitor
0,129  0,102  Sphingosine 1-phosphate receptor 5 antagonist
0,112  0,086  Alpha-N-acetylglucosaminidase inhibitor
0,070  0,045  Check point kinase 1 inhibitor
0,039  0,014  Benzodiazepine receptor peripheral-type antagonist
0,172  0,148  RNA-directed DNA polymerase inhibitor
0,128  0,104  Antifungal (Cryptococcus)
0,045  0,021  Acid-sensing ion channel blocker
0,145  0,121  Psychostimulant
0,159  0,135  Antialcoholic
0,066  0,043  Dopamine D1 antagonist
0,145  0,122  Non-steroidal antiinflammatory agent
0,066  0,044  Tyk2 inhibitor
0,152  0,130  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,071  0,049  Syk tyrosine kinase inhibitor
0,065  0,043  Cyclin A2 inhibitor
0,056  0,035  Immunoglobulin Fc receptor antagonist
0,135  0,114  CDC-like kinase 4 inhibitor
0,104  0,083  Carcinogenic, group 3
0,043  0,022  AMPA 4 receptor antagonist
0,141  0,122  Antimigraine
0,026  0,006  Toll-Like receptor 8 agonist
0,071  0,052  Polo-like kinase-2 inhibitor
0,068  0,049  SULT2A1 substrate
0,036  0,017  HCV NS5B polymerase inhibitor
0,118  0,099  Neurotrophic factor
0,130  0,112  Mcl-1 antagonist
0,040  0,022  Kainate receptor 2 antagonist
0,058  0,039  Phosphatidylinositol 3-kinase delta inhibitor
0,030  0,012  Toll-Like receptor 4 agonist
0,072  0,055  Adenosine A3 receptor antagonist
0,118  0,101  Sphingosine 1-phosphate receptor 2 antagonist
0,064  0,047  Fibroblast growth factor 2 antagonist
0,095  0,078  Granulocyte macrophage colony stimulating factor antagonist
0,107  0,091  TRKB antagonist
0,047  0,030  Purinergic P2X4 antagonist
0,023  0,006  Vesicular glutamate transport inhibitor
0,248  0,232  5 Hydroxytryptamine release inhibitor
0,092  0,076  Gastric antisecretory
0,063  0,047  Cyclin-dependent kinase 4 inhibitor
0,037  0,021  RNA-directed RNA polymerase inhibitor
0,085  0,070  MAO B inhibitor
0,059  0,045  Cyclin A inhibitor
0,132  0,118  Cytotoxic
0,029  0,014  Kainate receptor 4 antagonist
0,057  0,044  Biliverdin reductase inhibitor
0,143  0,130  Toxic, respiratory center
0,171  0,158  Respiratory analeptic
0,145  0,132  Systemic lupus erythematosus treatment
0,034  0,021  Transforming growth factor beta 2 antagonist
0,075  0,063  Histamine H1 receptor antagonist
0,033  0,021  Protein kinase C beta II inhibitor
0,039  0,027  Alpha 1d adrenoreceptor agonist
0,022  0,011  Retinoid X beta receptor antagonist
0,083  0,071  Antineoplastic, alkylator
0,043  0,032  Glutamate (mGluR group III) antagonist
0,119  0,108  SULT1A3 substrate
0,032  0,021  Potassium channel small-conductance Ca-activated activator
0,068  0,058  Phospholipase D inhibitor
0,039  0,029  CF transmembrane conductance regulator antagonist
0,138  0,128  Cyclin-dependent kinase 3 inhibitor
0,042  0,032  Nerve growth factor antagonist
0,037  0,027  Delayed rectifier potassium channel blocker
0,089  0,080  GABA C receptor agonist
0,128  0,119  Uterine stimulant
0,033  0,024  Protein kinase (CK2) beta inhibitor
0,115  0,107  Cytidine deaminase inhibitor
0,127  0,119  Liver fibrosis treatment
0,088  0,080  Phosphodiesterase 6D inhibitor
0,073  0,065  5 Hydroxytryptamine 2A antagonist
0,081  0,074  Tocolytic
0,042  0,035  Histamine H1 receptor agonist
0,143  0,136  Abortion inducer
0,064  0,057  MDM2 inhibitor
0,052  0,046  Cyclin E inhibitor
0,032  0,026  ATR kinase inhibitor
0,027  0,022  CDK4/cyclin D3 inhibitor
0,040  0,035  NMDA receptor subunit 3B antagonist
0,055  0,050  Alpha 2 adrenoreceptor agonist
0,105  0,101  Tyrosine-protein kinase receptor antagonist
0,097  0,094  TRKA antagonist
0,104  0,101  Phosphodiesterase inhibitor
0,087  0,084  UGT2B11 substrate
0,066  0,063  NAT1 substrate
0,083  0,080  Protein kinase (CK2) inhibitor
0,084  0,081  Sphingomyelinase inhibitor
0,069  0,066  Vanilloid 4 agonist
0,098  0,095  Microtubule formation inhibitor
0,019  0,017  Imidazoline I1 receptor antagonist
0,090  0,088  Adenylate kinase inhibitor
0,047  0,045  5 Hydroxytryptamine 4 antagonist
0,133  0,132  Antihelmintic
0,059  0,059  Phenylalanine 4-hydroxylase inhibitor
0,030  0,029  Antihyperaldosteronism
0,024  0,024  Complement factor 1s inhibitor
0,049  0,049  Phosphodiesterase II inhibitor

